122 related articles for article (PubMed ID: 28885731)
1. A multifunctional nanocarrier for efficient TRAIL-based gene therapy against hepatocellular carcinoma with desmoplasia in mice.
Liu CH; Chern GJ; Hsu FF; Huang KW; Sung YC; Huang HC; Qiu JT; Wang SK; Lin CC; Wu CH; Wu HC; Liu JY; Chen Y
Hepatology; 2018 Mar; 67(3):899-913. PubMed ID: 28885731
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of combining ING4 and TRAIL genes in cancer-targeting gene virotherapy strategy: first evidence in preclinical hepatocellular carcinoma.
Galal El-Shemi A; Mohammed Ashshi A; Oh E; Jung BK; Basalamah M; Alsaegh A; Yun CO
Gene Ther; 2018 Jan; 25(1):54-65. PubMed ID: 28925992
[TBL] [Abstract][Full Text] [Related]
3. Combined therapy with oncolytic adenoviruses encoding TRAIL and IL-12 genes markedly suppressed human hepatocellular carcinoma both in vitro and in an orthotopic transplanted mouse model.
El-Shemi AG; Ashshi AM; Na Y; Li Y; Basalamah M; Al-Allaf FA; Oh E; Jung BK; Yun CO
J Exp Clin Cancer Res; 2016 May; 35():74. PubMed ID: 27154307
[TBL] [Abstract][Full Text] [Related]
4. PTEN and TRAIL genes loaded zein nanoparticles as potential therapy for hepatocellular carcinoma.
El Sharkawi FZ; Ewais SM; Fahmy RH; Rashed LA
J Drug Target; 2017 Jul; 25(6):513-522. PubMed ID: 28140697
[TBL] [Abstract][Full Text] [Related]
5. Inhibiting survivin expression enhances TRAIL-induced tumoricidal activity in human hepatocellular carcinoma via cell cycle arrest.
He SQ; Rehman H; Gong MG; Zhao YZ; Huang ZY; Li CH; Zhang WG; Chen XP
Cancer Biol Ther; 2007 Aug; 6(8):1247-57. PubMed ID: 17700059
[TBL] [Abstract][Full Text] [Related]
6. The efficacy of combination therapy using adeno-associated virus-TRAIL targeting to telomerase activity and cisplatin in a mice model of hepatocellular carcinoma.
Wang Y; Huang F; Cai H; Wu Y; He G; Tan WS
J Cancer Res Clin Oncol; 2010 Dec; 136(12):1827-37. PubMed ID: 20213096
[TBL] [Abstract][Full Text] [Related]
7. Inorganic Kernel-Reconstituted Lipoprotein Biomimetic Nanovehicles Enable Efficient Targeting "Trojan Horse" Delivery of STAT3-Decoy Oligonucleotide for Overcoming TRAIL Resistance.
Shi K; Xue J; Fang Y; Bi H; Gao S; Yang D; Lu A; Li Y; Chen Y; Ke L
Theranostics; 2017; 7(18):4480-4497. PubMed ID: 29158840
[TBL] [Abstract][Full Text] [Related]
8. Bacteriophage-based particles carrying the TNF-related apoptosis-inducing ligand (TRAIL) gene for targeted delivery in hepatocellular carcinoma.
Sittiju P; Wudtiwai B; Chongchai A; Hajitou A; Kongtawelert P; Pothacharoen P; Suwan K
Nanoscale; 2024 Mar; 16(13):6603-6617. PubMed ID: 38470366
[TBL] [Abstract][Full Text] [Related]
9. Increased apoptosis induction in hepatocellular carcinoma by a novel tumor-targeted TRAIL fusion protein combined with bortezomib.
Wahl K; Siegemund M; Lehner F; Vondran F; Nüssler A; Länger F; Krech T; Kontermann R; Manns MP; Schulze-Osthoff K; Pfizenmaier K; Bantel H
Hepatology; 2013 Feb; 57(2):625-36. PubMed ID: 22991197
[TBL] [Abstract][Full Text] [Related]
10. 5, 7-Dimethoxyflavone sensitizes TRAIL-induced apoptosis through DR5 upregulation in hepatocellular carcinoma cells.
Yang JF; Cao JG; Tian L; Liu F
Cancer Chemother Pharmacol; 2012 Jan; 69(1):195-206. PubMed ID: 21660448
[TBL] [Abstract][Full Text] [Related]
11. TRAIL expression levels in human hepatocellular carcinoma have implications for tumor growth, recurrence and survival.
Piras-Straub K; Khairzada K; Trippler M; Baba HA; Kaiser GM; Paul A; Canbay A; Weber F; Gerken G; Herzer K
Int J Cancer; 2015 Feb; 136(4):E154-60. PubMed ID: 25123818
[TBL] [Abstract][Full Text] [Related]
12. Galectin-1 Modulates the Survival and Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Sensitivity in Human Hepatocellular Carcinoma Cells.
Li J; Sun RR; Yu ZJ; Liang H; Shen S; Kan Q
Cancer Biother Radiopharm; 2015 Oct; 30(8):336-41. PubMed ID: 26348206
[TBL] [Abstract][Full Text] [Related]
13. Augmenting the antitumor effect of TRAIL by SOCS3 with double-regulated replicating oncolytic adenovirus in hepatocellular carcinoma.
Wei RC; Cao X; Gui JH; Zhou XM; Zhong D; Yan QL; Huang WD; Qian QJ; Zhao FL; Liu XY
Hum Gene Ther; 2011 Sep; 22(9):1109-19. PubMed ID: 21361790
[TBL] [Abstract][Full Text] [Related]
14. Dovitinib sensitizes hepatocellular carcinoma cells to TRAIL and tigatuzumab, a novel anti-DR5 antibody, through SHP-1-dependent inhibition of STAT3.
Chen KF; Chen HL; Liu CY; Tai WT; Ichikawa K; Chen PJ; Cheng AL
Biochem Pharmacol; 2012 Mar; 83(6):769-77. PubMed ID: 22230479
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of SNAIL sensitizes hepatocellular carcinoma cells to TRAIL-induced apoptosis by regulating the NF-κB pathway.
Wan Z; Pan H; Liu S; Zhu J; Qi W; Fu K; Zhao T; Liang J
Oncol Rep; 2015 Mar; 33(3):1560-6. PubMed ID: 25607597
[TBL] [Abstract][Full Text] [Related]
16. Electroporation-mediated tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/Apo2L gene therapy for hepatocellular carcinoma.
Yamashita Y; Shimada M; Tanaka S; Okamamoto M; Miyazaki J; Sugimachi K
Hum Gene Ther; 2002 Jan; 13(2):275-86. PubMed ID: 11812283
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-138 enhances TRAIL-induced apoptosis through interferon-stimulated gene 15 downregulation in hepatocellular carcinoma cells.
Zuo C; Sheng X; Liu Z; Ma M; Xiong S; Deng H; Li S; Yang D; Wang X; Xiao H; Quan H; Xia M
Tumour Biol; 2017 Jun; 39(6):1010428317710410. PubMed ID: 28639887
[TBL] [Abstract][Full Text] [Related]
18. Adenoviral-mediated transfer of p53 gene enhances TRAIL-induced apoptosis in human hepatocellular carcinoma cells.
Inoue H; Shiraki K; Murata K; Sugimoto K; Kawakita T; Yamaguchi Y; Saitou Y; Enokimura N; Yamamoto N; Yamanaka Y; Nakano T
Int J Mol Med; 2004 Aug; 14(2):271-5. PubMed ID: 15254777
[TBL] [Abstract][Full Text] [Related]
19. MiR-106b inhibitors sensitize TRAIL-induced apoptosis in hepatocellular carcinoma through increase of death receptor 4.
Xu C; Shi L; Chen W; Fang P; Li J; Jin L; Pan Z; Pan C
Oncotarget; 2017 Jun; 8(26):41921-41931. PubMed ID: 28410209
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of miR-25 increases the sensitivity of liver cancer stem cells to TRAIL-induced apoptosis via PTEN/PI3K/Akt/Bad signaling pathway.
Feng X; Jiang J; Shi S; Xie H; Zhou L; Zheng S
Int J Oncol; 2016 Dec; 49(6):2600-2610. PubMed ID: 27840896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
